Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and…
| Price | $1.29 |
|---|---|
| Market cap | $19.06M |
| Sector | Technology |
| Industry | Software - Application |
| Exchange | NASDAQ |
| 52-week range | 0.62-3.15 |
| Beta | 0.58 |
Explore AIFF's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.